Pancreatic tumour with jaundice: good prognosis.

Diamantopoulos GI; Kapiris SA; Anagnostou E; Spiliadi C

doi:10.1177/014107680009300812

Pancreatic tumour with jaundice: good prognosis.

Diamantopoulos GI, Kapiris SA, Anagnostou E, Spiliadi C

Journal of the Royal Society of Medicine · 2000 · doi:10.1177/014107680009300812 · PMID:10983508 · PMC1298088

OA: closed

📄 Open PDF Full text JSON View on PubMed View at publisher

⚙ AI-generated summary by qwen3.7-flash+body, 2026-09-03 ⓘ

The provided text does not contain sufficient information to summarize the paper's findings regarding pancreatic tumours or their relation to endometriosis and adenomyosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-09-03 · read from full text ⓘ

The provided text contains only the title "Pancreatic tumour with jaundice: good prognosis" and a list of unrelated references, lacking the full article body necessary to determine specific study details or methods. Consequently, it is impossible to summarize the population, methodology, key findings, or limitations discussed in the research because the core content is absent. The available metadata indicates a focus on pancreatic pathology rather than gynecological disorders. The paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Full text 1,126 characters · extracted from oa-html · click to expand

Full Text The Full Text of this article is available as a PDF (119.5 KB). Selected References These references are in PubMed. This may not be the complete list of references from this article. - Anderson K. E., Spitz I. M., Sassa S., Bardin C. W., Kappas A. Prevention of cyclical attacks of acute intermittent porphyria with a long-acting agonist of luteinizing hormone-releasing hormone. N Engl J Med. 1984 Sep 6;311(10):643–645. doi: 10.1056/NEJM198409063111006. [DOI] [PubMed] [Google Scholar] - Merk K., Björkholm M., Tullgren O., Mellstedt H., Holm G. Immune deficiency in family members of patients with Hodgkin's disease. Cancer. 1990 Nov 1;66(9):1938–1943. doi: 10.1002/1097-0142(19901101)66:93.0.co;2-o. [DOI] [PubMed] [Google Scholar] - Sparano J. A., Dutcher J. P., Kaleya R., Caliendo G., Fiorito J., Mitsudo S., Shechner R., Boley S. J., Gucalp R., Ciobanu N. Colonic ischemia complicating immunotherapy with interleukin-2 and interferon-alpha. Cancer. 1991 Oct 1;68(7):1538–1544. doi: 10.1002/1097-0142(19911001)68:73.0.co;2-2. [DOI] [PubMed] [Google Scholar]

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-html ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc: last seen: 2026-09-27T09:11:36.575535+00:00
unpaywall: last seen: 2026-09-28T06:20:55.906821+00:00